London Institute of Cancer Research: Trial Design Could Improve Early-stage Cancer Studies Involving CAR-T Therapies
July 10, 2026
July 10, 2026
LONDON, England, July 10 (TNSjou) -- The Institute of Cancer Research issued the following news:
* * *
New trial design could improve early-stage cancer studies involving CAR-T therapies
Researchers have developed a new statistical approach that could help improve how early-stage cancer trials identify the safest and most effective doses of advanced therapies, such as CAR-T therapy.
The method, called DOSET (Dose Optimization with Simultaneous . . .
* * *
New trial design could improve early-stage cancer studies involving CAR-T therapies
Researchers have developed a new statistical approach that could help improve how early-stage cancer trials identify the safest and most effective doses of advanced therapies, such as CAR-T therapy.
The method, called DOSET (Dose Optimization with Simultaneous . . .